| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2024 | Sep 23, 2024 | Couchbase, Inc. | Director | Buy | 67.5 | +21,080 | 0.44% | ✗ | $298.5K |
| May 31, 2023 | Jun 2, 2023 | Lyra Therapeutics, Inc. | Director | Buy | 100.0 | +1,805,416 | 42.97% | ✗ | $4.4M |
| Apr 12, 2022 | Apr 14, 2022 | Lyra Therapeutics, Inc. | Director | Buy | 100.0 | +2,488,150 | 145.22% | ✗ | $10.5M |
| Jul 26, 2021 | Jul 26, 2021 | Couchbase, Inc. | Director | Buy | 92.5 | +166,666 | 3.67% | ✗ | $4M |
| May 5, 2020 | May 6, 2020 | Lyra Therapeutics, Inc. | Director | Buy | 95.0 | +225,817 | 7.65% | ✗ | $3.6M |
| Nov 29, 2012 | Feb 25, 2013 | Proto Labs Inc | 10% Owner | Sell | 26.3 | -1,400,610 | -41.12% | ✗ | $21.7K |
| Nov 21, 2012 | Nov 21, 2012 | Proto Labs Inc | 10% Owner | Sell | 15.0 | -1,417,500 | -29.38% | ✗ | $43.9M |
| Feb 29, 2012 | Mar 1, 2012 | Proto Labs Inc | 10% Owner | Buy | 96.3 | +430,000 | 7.18% | ✗ | $6.9M |